NCT05035524 A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19 Status UNKNOWN Phase NA
NCT05033847 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above Status UNKNOWN Phase PHASE2
NCT05028244 Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients Status COMPLETED Phase NA
NCT05019313 Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in the Positive COVID-19 Patient Status UNKNOWN Phase N/A
NCT05008380 Efficacy of the Early Prone-positioning in Hospitalized Patients With Mild Covid-19 Pneumonia Status COMPLETED Phase NA
NCT05002517 Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab Status UNKNOWN Phase PHASE3
NCT04997915 Acute Kidney Injury in Coronavirus Disease-19 (COVID-19) Patients Admitted to the Intensive Care Unit (ICU) Status COMPLETED Phase N/A
NCT04988282 Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease Status COMPLETED Phase PHASE4
NCT04987606 Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions Status COMPLETED Phase N/A
NCT04980534 Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip Status COMPLETED Phase NA
NCT04979221 Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19 Status UNKNOWN Phase PHASE3
NCT04978051 Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection Status COMPLETED Phase PHASE2
NCT04977934 Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 Status UNKNOWN Phase N/A
NCT04973488 Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients Status COMPLETED Phase NA
NCT04970719 Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus Status WITHDRAWN Phase PHASE3